�Researchers in Canada working on an international cogitation, discovered that the angiotensin-receptor blocker (ARB) telmisartan, a newer type of
drug for lowering blood air pressure, showed a modest decrease in cardiovascular deaths, strokes and fondness attacks in patients with heart problems and
diabetes who can't tolerate the standard and more wide used
